The global 3D cell culture market size was estimated at USD 1.57 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.22% from 2024 to 2030. The growth of the market can be attributed to the rising efforts to develop potential alternatives to animal-based testing and the availability of funding programs for research. Moreover, consistent efforts in R&D activities by biopharmaceutical companies for drug development & discovery, and emphasis on the adoption of 3D cell cultures in cancer research are other factors anticipated to fuel market growth over the projected period. Animal models are largely used in cellular-based studies for studying the outlook of various diseases. However, they carry several demerits such as a lack of response accuracy, differences in response from different species, etc. Thus, to manage these issues, various government organizations are involved in promoting alternative ways for drug development.

The COVID-19 pandemic had a significant impact on the market. The COVID-19 pandemic has presented researchers with the opportunity to investigate the novel contagious virus for the creation of therapeutic and diagnostic tools. Numerous prominent pharmaceutical and biotechnology companies have been engaging in extensive R&D efforts to produce innovative vaccines, therapies, and testing kits. As a result, there has been a substantial increase in the need for cell culture tools in research applications. Furthermore, the pandemic has increased the demand for new cell-based models, organoids, and high-throughput screening platforms for research & drug discovery efforts. The urgency to combat the pandemic increased the demand for bioreactors and culture systems for applications in vaccine production and drug testing.

Gather more insights about the market drivers, restrains and growth of the Global 3D cell culture market

3D Cell Culture Market Segments Highlights:

• The scaffold-based segment held the largest market share of 48.94% in 2023. The segment is further divided into hydrogels, polymeric scaffolds, micro patterned surfaced microplates, and nanofiber-based scaffolds.
• The scaffold free segment is expected to register the fastest CAGR over the forecast period. Factors such as enhanced cellular interactions, higher throughput, and scalability, rising demand for personalized medicine, and advancements in 3D culture model platforms and technologies are responsible for the fastest growth of the segment.
• Based on application, the market is segmented into cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others. The stem cell research & tissue engineering segment dominated the market with a share in 2023.
• The cancer research segment is expected to register the fastest CAGR over the forecast period. The rising prevalence of cancer and the benefits offered by 3D culture models in cancer research are expected to drive segment expansion.
• Based on end-use, the market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, hospitals, and others. The biopharmaceutical & pharmaceutical companies segment dominated the market with a share in 2023.
• The academic & research institutes segment is expected to register the fastest CAGR during the forecast period.
• North America dominated the market and accounted for a 38.97% share in 2023. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them.
• Asia Pacific is anticipated to witness the fastest growth in the market from 2024 to 2030.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Spatial Proteomics Market: The global spatial proteomics market size was estimated at USD 77.6 million in 2023 and is projected to grow at a CAGR of 14.76% from 2024 to 2030.
• Cancer Stem Cells Market: The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

3D Cell Culture Market Segmentation

Grand View Research has segmented the global 3D cell culture market based on technology, application, end-use, and region:

3D Cell Culture Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Scaffold Based
  • Hydrogels
  • Polymeric Scaffolds
  • Micro patterned Surface Microplates
  • Nanofiber Base Scaffolds
• Scaffold Free
  • Hanging Drop Microplates
  • Spheroid Microplates with ULA Coating
  • Magnetic Levitation
• Bioreactors
• Microfluidics
• Bioprinting

3D Cell Culture Application Outlook (Revenue, USD Billion, 2018 – 2030)

• Cancer Research
• Stem Cell Research & Tissue Engineering
• Drug Development & Toxicity Testing
• Others

3D Cell Culture End-Use Outlook (Revenue, USD Billion, 2018 – 2030)

• Biotechnology and Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals
• Others

3D Cell Culture Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Order a free sample PDF of the 3D Cell Culture Market Intelligence Study, published by Grand View Research.